---
layout: post
title:  "Melissa Strange joins Bind Research as CFO"
date:   2024-06-26 00:00:00 +0200
categories: fro
author: Bind team
excerpt_separator: <!--more-->
---
<div class="post-sidebyside">
    <div class="text">
        <p>Bind Research is delighted to welcome Melissa Strange in her new role as Chief Financial Officer.</p>
        <!--more-->
        <p>Melissa Strange is a commercially-minded senior finance leader with over 16 years worth of experience in life sciences companies. Melissa has been involved from early-stage research through clinical development and into commercial phases, and has worked across biotech, healthtech and medtech, where she has provided expertise in financial strategy, tax management and has supported a range of commercial and corporate transactions, including significant dilutive and non-dilutive funding. Prior to joining Bind Melissa served as Chief Financial Officer at Infinitopes, Brainomix and Closed Loop Medicine and was VP, Finance for Summit Therapeutics, a NASDAQ listed biotech. Melissa is also Chair of the Finance and Tax Advisory Committee at the BioIndustry Association. Melissa will be overseeing Bindâ€™s financial operations and legal aspects.</p>
    </div>
    <img src="{{ site.baseurl }}/assets/images/Mel.jpg">
</div>
